We have devised a reproducible protocol by which human embryonic stem cells (hESCs) or inducible pluripotent stem cells (iPSCs) are efficiently differentiated to functional spinal motor neurons. This protocol comprises four major steps. Pluripotent stem cells are induced to form neuroepithelial (NE) cells that form neural tube-like rosettes in the absence of morphogens in the first 2 weeks. The NE cells are then specified to OLIG2-expressing motoneuron progenitors in the presence of retinoic acid (RA) and sonic hedgehog (SHH) or purmorphamine in the next 2 weeks. These progenitor cells further generate post-mitotic, HB9-expressing motoneurons at the 5th week and mature to functional motor neurons thereafter. It typically takes 5 weeks to generate the post-mitotic motoneurons and 8-10 weeks for the production of functional mature motoneurons. In comparison with other methods, our protocol does not use feeder cells, has a minimum dependence on proteins (purmorphamine replacing SHH), has controllable adherent selection and is adaptable for scalable suspension culture.
INTRODUCTION
Directed differentiation of specific lineages from human embryonic stem cells (hESCs) is the first critical step toward the use of hESCs in understanding early human development and potential future application in the clinic. In the past decade, various protocols have been developed to differentiate hESCs to cells of the neural lineage, including neuroepithelial (NE) cells 1 , spinal motor neurons 2, 3 , midbrain dopamine neurons [4] [5] [6] , cerebral glutamate and g-butyric acid (GABA) neurons 7, 8 , astrocytes and oligodendrocytes 9, 10 . These protocols vary considerably in the state of the starting hESCs, use of feeders for co-culture, presence of unknown factors (e.g., sera and conditioned media), differentiation efficiency and purity of the target cell type 11 . Hence, these protocols may be useful for certain applications but not others. The series of neural differentiation protocols we have developed over the past decade, including the one described here, were devised to fulfill several objectives: creating a model for dissecting the cellular and molecular interactions underlying early human brain development, producing enriched/pure populations of functional neural cell types for the development of therapeutics and modeling diseases with humaninduced pluripotent stem (iPS) cell-derived motoneurons for investigating the pathogenesis and screening of drugs. We therefore follow the developmental principles and use chemically defined media for controllability and reproducibility of cell culture. This protocol almost always leads to a high efficiency in production of the target cell type without losing the simplicity of the culture system and medium components.
In the mouse, spinal motor neurons are differentiated from NE cells in a very narrow band of the ventral neural tube known as the pMN domain. These progenitor cells express the helix-loop-helix transcription factor Olig2. The specification of the Olig2-expressing motoneuron progenitors is strictly dependent on a particular amount of sonic hedgehog (SHH) that is secreted from the notochord 12, 13 . Through interaction with neurogenic transcription factors including Ngn2 and PAX6, the Olig2-expressing progenitors differentiate to post-mitotic motor neurons during the neurogenesis phase. These post-mitotic motor neurons express motoneuron-specific transcription factors such as HB9 and Isl1, whereas Olig2 is downregulated [14] [15] [16] [17] . HB9-expressing motoneuorns further differentiate and express choline acetyltransferase (ChAT), an enzyme catalyzing acetylcholine synthesis for signal conduction through the neuromuscular junctions. As for humans, it is generally predicted that human motor neurons are generated following a similar process. Based on the evidence from limited studies on human embryos, it can be inferred that spinal motoneuron progenitors appear in the developing human spinal cord at the end of the 5th gestation week and motor neurons in the ventral horn in the following week 18, 19 .
The generation of spinal motoneurons from hESCs follows the same basic steps as shown in the development of the spinal cord (Fig. 1) . The hESCs are initially suspended in ESC growth medium for 4 d to support cell survival and to initiate the differentiation process. The cells are then transferred to a serum-free neural differentiation medium in order to guide the cells toward the neuroectoderm fate in the next 10 d (ref. 20) . During the neural induction phase, the hESC aggregates are reseeded from day 7 onto a culture surface without feeder cells to form individual colonies of monolayer cells. This allows even exposure of the cells to the medium for a synchronized differentiation and easy observation of morphological changes over time. The adherent nature of the cells also allows for easy purification in case there are non-neural colonies. By 2 weeks of differentiation (days 14-17), NE cells develop, which can be easily and reliably identified by the presence of neural tube-like rosettes 1 and by the expression of a host of neuroectoderm transcription factors including PAX6 and SOX1. Interestingly, by default, almost all of the NE cells carry an anterior phenotype by expressing OTX2 (ref. 20) . Therefore, the second step is to treat the anterior NE cells with retinoic acid (RA) and SHH in the next 2 weeks, in order to produce OLIG2-expressing ventral spinal progenitors. We discovered that the early NE cells at day 10, also referred to as primitive NE cells 20 , are much more responsive to RA; thus, RA is added at day 10 in our protocol 2, 21 . These OLIG2-expressing cells then differentiate to spinal motoneurons in the 5th week and express transcription factors such as HB9 and Isl1. These motoneurons, when further cultured in the presence of neurotrophic factors, extend long axonal projections, express ChAT and become electrophysiologically active. When co-cultured with myoblasts, these hESC-derived motoneurons form neuromuscular junctions.
The protocol described here is optimized from our earlier reports 2, 21 . We have made a number of modifications to streamline the procedure and improve the yield owing to the availability of the more potent recombinant SHH (resulting from a mutation at the N terminus) and the discovery of small molecules for activating the hedgehog pathway that work in human cells. The optimized protocol typically generates over 50% of HB9-expressing motoneurons from the original hESC progenies. This protocol has also been shown to be effective for motoneuron differentiation from iPS cells 22 . This protocol is thus useful for dissecting molecular interactions underlying human motoneuron specification under a defined condition, following pathological changes in motoneuorns (that are derived from transgenic stem cells and disease iPS cells), developing motoneuron templates for drug screening and generating functional motoneurons for potential cell therapy in diseases involving motoneurons.
Experimental design
This protocol critically depends on the quality of hESCs. The starting hESCs (lines H1 and H9), maintained on mouse embryonic fibroblast (MEF) feeder, should exhibit a uniform undifferentiated phenotype (Fig. 2a,b) . hESCs expanded in feeder-free conditions and partially differentiated hESCs generally result in a lower neural differentiation efficiency. Quality MEFs are essential for maintaining the undifferentiated state of hESCs. Before use, it is necessary to test each batch of MEFs on at least two hESC lines for no less than three passages.
The neural differentiation process begins with the lifting of hESC colonies from MEF feeder layers. The detachment of hESCs from MEFs and the formation of aggregates in suspension (also known as embryoid bodies) initiate the differentiation process. The hESC aggregates are usually grown as free-floating spheres in regular cell culture dishes or flasks so that any contaminating MEFs will attach to the flask. These fibroblasts can then be easily removed by transferring the floating ESC aggregates to a new culture vessel. The differentiation process does not require exogenous growth factors such as FGFs or noggin, a BMP antagonist, as these factors are produced by the differentiating cells 23 . The addition of noggin could help the neural differentiation, if the hESCs are partially differentiated.
A unique aspect of the differentiation protocol is the adherence of the hESC aggregates to the culture surface from day 7. The attached aggregates form individual monolayer colonies, permitting continual observation of morphological differentiation. This also allows enrichment of NE colonies by manually scraping off the non-neural colonies. Although the hESC aggregates can attach to the culture surface, coating the culture surface with laminin enhances the adherent process. The cells should be seeded so that after 7 d of growth individual colonies remain separated from each other. Using a higher cell density will compromise the neural differentiation, as autocrine and/or paracrine signaling through the TGFb signaling will inhibit neural differentiation.
The first sign of neural differentiation is the appearance of columnar epithelial cells that line up radially like rosettes at around 10 d of hESC differentiation 1, 2, 20 . Surrounding the neural epithelial rosettes are round spreading cells that are likely to be of the neural crest lineage (Fig. 2c) . The NE cells at this stage express PAX6 but not SOX1 (Fig. 2d) . We refer to these cells as primitive NE cells, as these cells can be patterned to versatile neural cell types 1, 2, 20 .
The columnar NE cells proliferate quickly and form neural tubelike rosettes after an additional 4 d of culture (Fig. 2e) . We refer to these cells as definitive NE cells 1, 2, 20 . Immunostaining will indicate that these cells express both PAX6 and SOX1 (Fig. 2f) flat cells in the surrounding area attach more tightly. Therefore, gentle pipetting of the colony will blow the neural rosettes off but leave the surrounding flat cells behind.
Colonies that do not possess rosettes are usually non-neural colonies. Those colonies can be observed under a microscope and scraped off using a pipette tip. This will minimize, if not eliminate, the contamination of non-neural cells. The NE cells differentiated from hESCs in the absence of morphogens bear an anterior identity and express forebrain and midbrain markers such as OTX2 and BF1 (refs. 2,20) . Hence, we choose RA, a caudalizing factor, and SHH, a ventralizing morphogen, for inducing the ventral spinal progenitor fate 24, 25 . We have discovered that the primitive but not the definitive NE cells are responsive to morphogens for regional patterning 2 . We therefore treat the NE cells with RA at day 10 for motoneuron specification 2 . By carefully titrating the concentrations, we found that RA at 100 nM is sufficient to pattern OTX2-expressing primitive NE cells to progenitors with upper spinal cord identity, which express HOXB4 2 ( Fig. 3a-d) . From day 15, after lifting off rosettes, the spinal cord progenitors are then directed to a ventral fate with recombinant SHH (100 ng ml À1 ), which can be marked by OLIG2 expression. Recently, we discovered that purmorphamine, a small molecule targeting smoothened of the SHH signaling pathway, can replace SHH for motor neuron specification. Purmorphamine has a narrow working concentration range (0.5-1.5 mM) and 1 mM of purmorphamine can efficiently induce OLIG2 expression.
From day 15, the cells grow quickly in suspension and form large NE spheres. In order for growth factors and morphorgens to penetrate into the compact clusters, those clusters larger than 300 mm need to be broken into smaller ones. We usually triturate the clusters using a curved Pasteur pipette without dissociating them to single cells. Dissociation of the progenitor clusters into single cells will significantly reduce the yield of post-mitotic motor neurons. This requires the preparation of the Pasteur pipette to a right angle with an appropriate aperture 26 . A brief digestion with Accutase, that contains proteolytic and collagenolytic enzymes, can also achieve the dissociation of large clusters to smaller ones (Fig. 4a) .
On day 28, OLIG2-expressing motoneuron progenitors appear. For differentiation of post-mitotic motoneurons, the OLIG2-expressing progenitor clusters are grown on substrates such as laminin. Two days after plating, the spheres spread out and neurites extend from the spheres (Fig. 4b) . Neurotrophic factors, brain-derived neurotrophic factor (BDNF), glial-derived neurotrophic factor (GDNF), insulin-like growth factor-1 (IGF1), and cAMP are added to support the survival and process outgrowth of motoneurons. The concentration of SHH and RA is reduced as high concentrations of SHH or RA inhibit motoneuron differentiation at this stage. At day 35, HB9-expressing motoneurons increase in number, whereas the OLIG2-expressing progenitors decrease (Fig. 4c) . The HB9+ neurons also express bIII-tubulin (Fig. 4d) and are positive for the LIM domain transcription factor ISL1/2. Under the optimal condition, this protocol yields B50% HB9+ motoneuron among the total differentiated progenies. It should be noted that some commercially available antibodies against HB9 are not specific and cannot be reliably used as a marker of spinal cord motoneurons. Hence, multiple motoneuron-related markers such as ISL1 and LHX3 should be investigated as well as HB9. In general, cells positive for both HB9 and ISL1 are considered to be motoneurons. As a positive control, embryonic spinal cord tissues can be reliably used for ascertaining the specificity of the HB9 antibodies. In our hands, MNR2 (HB9, monoclonal antibody, Developmental Studies Hybridoma Bank (DSHB; ref. 21), 81.5C10) specifically labels motoneurons in vitro and in vivo. Both OLIG2-and HB9-stained cells can also be quantitated with fluorescence-activated flow cytometry.
ChAT catalyzes acetylcholine synthesis in cholinergic neurons, which in the ventral spinal cord is exclusively expressed in motoneurons. In the hESC-derived motoneurons, ChAT-positive motor-neurons begin to appear at around the 6th week (days 40-42) and increase in number overtime; meanwhile, HB9-expressing cells decrease. During the 6th and 7th weeks, some cells express HB9 in the nucleus and ChAT in the cytoplasm and neurites (Fig. 4e) . The available ChAT antibodies usually give rise to a high background when staining cultured cells that are fixed with paraformaldehyde (PFA) only. The addition of 0.2% (vol/vol) picric acid in the fixative buffer will fix the enzyme better and minimize the background.
The motoneurons growing on the substrate can be maintained for several weeks. When co-cultured with myocytes, the motoneuron axons induce acetylcholine receptor clustering, which can be visualized by fluorescently labeled a-bungarotoxin (Fig. 4f) . Stericup filtration system (Millipore, cat. no. SCGPU05RE, 500 ml) . Steriflip filtration system (Millipore, cat. no. SCGP00525, 50 ml)
REAGENT SETUP hESC growth medium (500 ml) In a sterile environment, mix 392.5 ml of DMEM-F12, 100 ml of KnockOut serum replacement, 5 ml of MEM non-essential amino acids solution, 2.5 ml of 200 mM L-glutamine solution (final concentration of 1 mM) and 3.5 ml of 14.3 M of 2-ME (final concentration of 0.1 mM). The medium can be stored at 4 1C for up to 7-10 d. ! CAUTION 2-ME is combustible, corrosive and toxic in case of ingestion and skin absorption; keep away from sources of ignition; avoid direct contact. KnockOut serum replacement Store the 500-ml stock at À80 1C. Use up the thawed serum replacement within a week. If it cannot be used up, then prepare aliquots of 50 ml and store at À20 1C for up to 4 weeks. Neural differentiation medium (DMEM/F12/N2, 500 ml) In a sterile environment, mix 489 ml of DMEM/F12, 5 ml of N2 supplement, 5 ml of MEM non-essential amino acids solution and 1 ml of 1 mg ml À1 heparin. The medium can be stored at 4 1C for up to 2 weeks. For neuronal differentiation, add cAMP (1:10,000), ascorbic acid (1:1,000), BDNF (1:10,000), GDNF (1:10,000) and IGF-1 (1:10,000) immediately before use. m CRITICAL The neuronal differentiation medium should be made up fresh each day. Dispase (1 U ml À1 ) Dissolve 50 U of dispase in 50 ml of F12/DMEM medium; warm at 37 1C for 15 min; and filter using a 50-ml Steriflip. The solution can be stored at 4 1C for up to 2 weeks. m CRITICAL Note that the amount of dispase (U ml À1 ) varies among lots. Trypsin inhibitor (1 mg ml À1 ) Dissolve 50 mg of trypsin inhibitor in 50 ml of DMEM/F12 and filter through a 50-ml Steriflip. Store at 4 1C and use within 2 weeks. Heparin (1mg ml À1 ) Dissolve 10 mg of heparin in 10 ml of DMEM medium, aliquot and store at À80 1C for up to 3 months. FGF2 (100 lg ml À1 ) Dissolve 100 mg of bFGF in 1 ml of sterilized PBS with 0.1% BSA (wt/vol). Store at À80 1C for up to 3 months. BDNF, GDNF and IGF1 (100 lg ml À1 ) Dissolve 100 mg of growth factor in 1 ml of sterilized distilled water, aliquot and store at À80 1C for up to 3 months. SHH (100 lg ml À1 ) Dissolve 100 mg of SHH in 1 ml of sterilized PBS with 0.1% BSA (wt/vol). Aliquot 100 ml into sterilized tubes and store at À80 1C for up to 3 months. Purmorphamine (10 mM) Dissolve 5 mg of purmorphamine in 480 ml of 100% ethanol and 480 ml of DMSO, aliquot and store at À20 1C for up to 8 weeks. 1| Grow hESCs in a six-well MEF plate with 2.5 ml of hESC medium containing 4 ng ml À1 of FGF2 until they form colonies, express OCT4 uniformly 1 and are ready to be subcultured ( Fig. 2a and b) . Incubate the cells at 37 1C, 5% CO 2 .
2| Warm DMEM/12 and dispase to 37 1C for 10 min.
3|
Remove the old medium from the cells and rinse each well of hESCs with 2 ml of DMEM/F12 for 2 min.
4|
Remove the DMEM/F12 medium.
5| Add 1 ml of freshly prepared dispase (1 U ml À1 ) to each well of a six-well plate; incubate the cultures at 37 1C for 3-5 min. m CRITICAL STEP Inspect the cells every 3 min. Do not incubate the cells in dispase for too long.
6| Aspirate the dispase from the cells when the edge of the hESC colonies begin to curl.
7| Gently rinse the cells with 2 ml of DMEM/F12 medium. m CRITICAL STEP The hESC colonies are now loosely attached and are very easy to be washed away. Remove the medium carefully without disturbing the colonies.
8| Add 2 ml of fresh hESC medium to each well.
9| Lift the colonies off by gently swirling the plate.
10| Gently blow off the colonies remaining attached to the plate using a 5-ml serological pipette or a 1,000-ml pipette tip. Pipette the hESC colonies to the size of 50-100 mm. m CRITICAL STEP Do not pipette the cells more than five times.
11| Collect the colonies into a 15-ml conical tube and centrifuge for 1 min, at 50g at room temperature. Alternatively, let the hESC colonies sink by leaving the tube to stand for 3 min.
12| Aspirate the medium gently without disturbing the pellet or colonies.
13| Re-suspend the hESC colonies with 5 ml of fresh hESC medium, and wash the cells once by repeating Steps 11 and 12.
14| Re-suspend the hESC colonies with 5 ml of hESC medium without FGF2.
15|
Transfer the cells to a T75 culture flask. Cells from one six-well plate should be transferred to one T75 flask with 40 ml of hESC medium.
16| Record the date when hESC colonies are lifted off from feeder cells as day 0 of hESC differentiation and culture the cells for 24 h at 37 1C, 5% CO 2 .
17|
The following day (day 1), allow the flask to stand and let the aggregates sink for 5 min. The hESC colonies generally round up as individual spheres with some individual cell debris floating in the culture. Debris attaching to the cell clusters can be stripped off by pipetting the culture using a 10-ml serological pipette.
18| Remove the old medium and re-suspend the hESC aggregates with 40 ml of fresh hESC medium.
19|
Transfer the culture to a new T75 flask and culture the cells in suspension at 37 1C, 5% CO 2 .
20| Observe the cells daily. Feed the cells every day by replacing the old medium with fresh hESC medium using the same procedure described in Steps 17-19. ? TROUBLESHOOTING 21| On day 4, switch the culture medium to the neural differentiation medium and feed the cells repeating Steps 17-19 every other day.
? TROUBLESHOOTING 22| On day 7, collect the hESC aggregates into a 50-ml conical tube, centrifuge for 2 min at 50g at room temperature. An additional wash with DMEM/F12 medium is optional to remove the dead cells and facilitate the attachment of the clusters to the culture surface.
23|
Aspirate the medium and re-suspend the hESC aggregates with 5 ml of neural differentiation medium. 25| Carefully pick the hESC aggregates from the Petri dish using a 200-ml pipette. Seed 20-25 clusters of cells evenly to each well of a laminin-coated six-well plate in 300 ml of neural differentiation medium. Do not let the medium drain to the edge of the well. Incubate the culture at 37 1C, 5% CO 2 overnight. m CRITICAL STEP Seed the colonies evenly.
26| On day 8, observe the attachment of cell aggregates under a microscope and add 2 ml of neural differentiation medium.
Incubate the culture at 37 1C, 5% CO 2 for 48 h. ? TROUBLESHOOTING Specification of Olig2-expressing motoneuron progenitors TIMING 18 d (days 10-28) 27| On day 10, observe the cultures under the microscope. Evaluate the differentiation efficiency by counting the clusters with obvious early rosettes (Fig. 2e) .
28| Replace the old medium in each well with 2 ml of fresh neural differentiation medium containing 0.1 mM of RA (1:10,000 dilution of the stock solution). Incubate the culture at 37 1C, 5% CO 2 for 48 h.
29|
On days 12 and 14, feed the culture with the same medium and procedures as those described in Step 28.
30| On day 15, carefully observe the cells for neural tube-like rosettes (Fig. 2e) ; mark out those colonies that do not possess typical rosettes using a microscope object marker.
? TROUBLESHOOTING 31| Gently swirl the plate and then remove the old medium.
32| Add 2 ml of fresh neural differentiation medium to each well of the six-well plate.
33| Gently blow the clusters using a 1-ml pipette to detach the neural tube-like rosettes in the colonies. m CRITICAL STEP Keep the pipette tip within the medium to avoid bubbles when pipetting. Flat cells at the peripheral part of the colony should remain attached. Avoid lifting those colonies marked in Step 30.
34|
Transfer the cell clusters into a 15-ml conical tube using a 1-ml pipette.
35| Put a 10-ml pipette in the conical tube; let the pipette tip gently touch the bottom. Pipette the cell clusters by taking in all the clusters and then blowing them out. Pipette two or three times. m CRITICAL STEP Do not break the clumps to single cells or clusters smaller than 100 mm.
36| Centrifuge the cell clusters for 2 min at 50g, room temperature.
37| Aspirate the old medium from the tube; add 5 ml of fresh neural differentiation medium containing B27, SHH (100 ng ml À1 ) and RA (0.1 mM). As an option, purmorphamine at 1 mM can replace SHH from this step onward.
38|
Transfer the cell clusters from 1-2 plates into a T75 flask (alternatively, cells from three wells may be added to one T25 flask). Culture the cells at 37 1C, 5% CO 2 for 48 h.
39|
On days 17 and 19, allow the flask to stand for 2-3 min and let the cell clusters settle to one corner. Aspirate 30 ml of the supernatant without disturbing the clusters. Add 30 ml of fresh neural differentiation medium described in Step 37.
? TROUBLESHOOTING 40| On day 20, break the spheres bigger than 300 mm using either option A a fire polished Pasteur pipette or Option B, by incubating large clusters (4300 mm) with 1 ml of Accutase at 37 1C for 3 min followed by gentle pipetting. (vii) Take all the clusters into the glass pipette using the pipette aid. Blow out the spheres with force into the medium in the flask. ? TROUBLESHOOTING (viii) Culture the cells at 37 1C, 5% CO 2 for 48 h.
(ix) Replace 25 ml of old medium with the same volume of fresh medium using the medium and procedures described in Step 39.
(B) Splitting big neurospheres using Accutase TIMING 30 min (xi) The next day, using the medium and procedures described in Step 39, remove 10 ml of old medium and add back 20 ml of fresh medium.
41| On day 23, plate some clusters onto a coverslip (Box 1) to immunostain for OLIG2 2 . On days 24 and 26, feed the cell clusters in suspension using the same medium and procedures as described in Step 39.
Generation of spinal motor neurons by differentiation on the substrate TIMING 7 d (days 28-35)
42| On day 28, using the procedures described in Box 1, plate 3-5 spheres onto a glass coverslip coated with poly-L-ornithine and laminin. Culture the cells in 50 ml of neural differentiation medium supplemented with BDNF, GDNF, IGF1 (each at 10 ng ml À1 ), cAMP (1 mM) and ascorbic acid (AA, 200ng ml À1 ). RA and SHH concentrations are now reduced to 50 nM and 50 ng ml À1 , respectively. Culture the rest of the motoneurons using the procedures described in ANTICIPATED RESULTS Before starting the differentiation protocol, well-maintained hESCs should be uniformly positive for pluripotent markers such as OCT4 (Fig. 2b) . In the neural induction period (first 2 weeks), at least 90% of the total differentiated cells are NE cells that express PAX6 and later PAX6 and SOX1 (Fig. 2c-f) . This is based on our study on multiple hESC lines over the past decade, including H1 and H9. If the non-neural colonies are scraped before collecting and assessing the neural population (Steps 30-38), the PAX6+ cell population should be 95-99%. NE differentiation efficiency below 90% is almost always caused by the poor quality of the starting hESCs.
The primitive NE cells cultured in the presence of RA are caudalized to HOXB4-expressing spinal progenitors, whereas those without RA retain an anterior identity by expressing OTX2 (Fig. 3) . On day 15, the cells are lifted off and grown in suspension as spheres (Fig. 4a) . About 50% of the total cells will be positive for OLIG2 at the end of the 4th week when SHH is used in the entire protocol. When purmorphamine is used in this protocol, the proportion of OLIG2-expressing cells is 60-80% and the population peaks in the middle of the 4th week.
The OLIG2-expressing motoneuron progenitors grown on substrate differentiate to HB9-expressing post-mitotic motor neurons in the 5th week. By the end of the 5th week, the cells protrude long processes (Fig. 4b) , and the HB9-expressing cells account for 30-40% of the total population, whereas OLIG2 cells decrease to o30% (Fig. 4c) . Most of the HB9 cells are also Tuj1+ (Fig. 4d) , indicating that these cells exit the cell cycle and commit to the neuronal lineage. The HB9-expressing cells generally remain in clusters, rarely migrating away from the cluster (Fig. 4d) . Dissociation of the OLIG2-expressing progenitor spheres often results in a reduced population of motor neurons.
After the 5th week, the motor neurons can be further cultured for several weeks or months depending on the applications. This will lead to expression of mature motoneuron markers such as ChAT (Fig. 4e) . When co-cultured with myoblasts (C2C12, ATCC CRL-1772) for 2 weeks, the motoneurons begin to express synapsin, a vesicle protein required for transmitter release and appropriate signal transduction across synapses (Fig. 4f) . The myotubes in contact with the neurites often express clusters of acetylcholine receptors, which can be detected through their binding to fluorephore-conjugated a-bungarotoxin (Fig. 4f) . 
